Search
Xilio Therapeutics Inc
XLOAdd to Watchlist
9.220USD
-0.360-3.76%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
55.16MMarket Cap
LossP/E TTM
Xilio Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
43.77M
589.88%
EPS(YoY)
-58.66
-284.98%
Analyst Rating
STRONG BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its total revenue reached 43.77M, with a year-on-year change of 589.88.
What are the current assets of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its current assets were 145.03M, with a year-on-year change of 140.77.
What are the total assets of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its total assets of Xilio Therapeutics Inc were 154.69M, with a year-on-year change of 117.64.
What are the total liabilities of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its total liabilities of Xilio Therapeutics Inc were 119.41M, with a year-on-year change of 123.30.
What is the total equity of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its total equity of Xilio Therapeutics Inc was 35.27M, with a year-on-year change of 100.44.
What is the net investment of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its net investment of Xilio Therapeutics Inc was -518.00K, with a year-on-year change of -1338.89.
What is the net financing of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its net financing of Xilio Therapeutics Inc was 87.78M, with a year-on-year change of 200.64.
What is the Earnings Per Share (EPS) of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -58.66, with a year-on-year change of -284.98.
What is the net margin of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its net profit margin was -80.05, with a year-on-year change of 91.28.
What is the Return on Equity (ROE) of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -132.53, with a year-on-year change of 38.07.
What is the Return on Assets (ROA) of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -31.04, with a year-on-year change of 64.83.
What is the operating profit of Xilio Therapeutics Inc?
According to Xilio Therapeutics Inc's FY2025 earnings report, its operating profit was -41.98M, with a year-on-year change of 29.61.